|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| A61K 39/39558 | (2013.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 31/47 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/2827 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 35/04 | (2018.01) |
| (11) | Number of the document | 3570840 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18709192.1 |
| Date of filing the European patent application | 2018-01-19 | |
| (97) | Date of publication of the European application | 2019-11-27 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/014523 |
| Date | 2018-01-19 |
| (87) | Number | WO 2018/136796 |
| Date | 2018-07-26 |
| (30) | Number | Date | Country code |
| 201762448869 P | 2017-01-20 | US | |
| 201762458447 P | 2017-02-13 | US |
| (72) |
SCHWAB, Gisela , US
SCHEFFOLD, Christian , US
HESSEL, Colin , US
|
| (73) |
Exelixis, Inc. ,
1851 Harbor Bay Parkway, Alameda, CA 94502,
US
|
| (54) | COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER |
| COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER |